Markets:

Overview

News

Currencies

International

Treasuries

Pacific Biosciences of California, Inc. - Common Stock (NQ:PACB)

1.610 -0.020 (-1.23%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pacific Biosciences of California, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Cathie Wood's Ark Invest Purchases $9.5M Worth Of Robinhood Shares, Downsizes Holdings Of Grayscale Bitcoin Investment Trust ↗

November 08, 2023

Via Benzinga

Analyst Expectations for Pacific Biosciences's Future ↗

November 06, 2023

Via Benzinga

Cathie Wood Just Added $5 Million of This Stock After It Had a Steep Pullback. Is It a No-Brainer Buy? ↗

October 18, 2023

This innovator is targeting a huge, rapidly growing market.

Via The Motley Fool

7 Analysts Have This to Say About Pacific Biosciences ↗

October 16, 2023

Via Benzinga

Cathie Wood Goes Shopping For Stock of Jack Dorsey's Block — Ark Invest Bolsters Portfolio With Archer Aviation, CRISPR Shares ↗

October 09, 2023

Via Benzinga

5 Analysts Have This to Say About Pacific Biosciences ↗

September 26, 2023

Via Benzinga

Analyst Expectations for Pacific Biosciences's Future ↗

August 22, 2023

Via Benzinga

The Latest Analyst Ratings for Pacific Biosciences ↗

August 03, 2023

Via Benzinga

Earnings Scheduled For October 30, 2023 ↗

October 30, 2023

Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter.

Via Benzinga

Pacific Biosciences's Earnings Outlook ↗

October 27, 2023

Via Benzinga

Cathie Wood's Ark Invest Sells Over $25M Worth Of Tesla Shares Amid Boost In Price ↗

October 04, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023 ↗

September 28, 2023

Via Benzinga

Analyst Ratings for Pacific Biosciences ↗

June 30, 2023

Via Benzinga

Where Pacific Biosciences Stands With Analysts ↗

June 05, 2023

Via Benzinga

Expert Ratings for Pacific Biosciences ↗

May 04, 2023

Via Benzinga

Cathie Wood's Buying These 3 Stocks Hand Over Fist ↗

September 08, 2023

A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team.

Via The Motley Fool

Rising Fuel Costs Lead To Win For Energy, Cathie Wood's Biotech Play Loses Big - ETF Winners And Losers: Medium-Cap Returns ↗

August 14, 2023

We performed a screening of medium-cap ETFs, defined as having Assets Under Management (AUM) between $2 billion and $10 billion - to determine what funds had the largest positive and negative returns...

Via Benzinga

Topics ETFs

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

August 09, 2023

The growth-focused money manager is making moves, with her ETFs beating the market again in 2023 after terrible returns the two previous years.

Via The Motley Fool

Palantir Post Q2 Earnings Share Price Dip Doesn't Deter Cathie Wood — Ark Invest Buys $14M Worth Of Shares ↗

August 08, 2023

Via Benzinga

Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports ↗

August 07, 2023

Via Benzinga

PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care

August 07, 2023

Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms

From GeneDx Holdings Corp.; PacBio

Via GlobeNewswire

Cathie Wood's Ark Invest Acquires $5.5M of Robinhood Shares Following Platform's First Profitable Quarter ↗

August 03, 2023

Via Benzinga

Thoughts For Thursday: Back From The Holiday With Caution ↗

July 06, 2023

Caution is perhaps what was reflected in yesterday's back from the holiday trading. One there is the question of upcoming Fed action and second there is the visit of Secretary Yellen to China.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023 ↗

June 30, 2023

Via Benzinga

Market Mixes It Up With A Broad Rally ↗

June 05, 2023

Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive.

Via Talk Markets

Time To Play Small Cap Life Science Stocks ↗

May 15, 2023

The overall market sentiment has been hit hard by MACRO concerns. The dominating narrative is the Fed and the Debt Ceiling.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023 ↗

May 10, 2023

Via Benzinga

Something Happened In Biotech Last Week ↗

May 08, 2023

Biotech stocks were more constructive last week with some sharp moves up.

Via Talk Markets

Cathie Wood Scoops Up AMD Stock On A Day When It Tanks Over 9%: Also Raises Stake In This Biotech Company ↗

May 03, 2023

Via Benzinga

Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector ↗

May 01, 2023

A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro...

Via Talk Markets

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Pacific Biosciences of California, Inc. - Common Stock (NQ:PACB)

All News about Pacific Biosciences of California, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today